Apolizumab ( 阿泊珠单抗 )

产品名称：Apolizumab ( 阿泊珠单抗 )；

产品编号：YR1018；

分子名称：Apolizumab；

克隆性：Monoclonal；

产品别称：Hu1D10, Apolizumab, 267227-08-7；

关键词：Apolizumab, 267227-08-7, 1D10, HU1D10, K8-355, HLA-DRB1, major histocompatibility complex, class II, DR beta 1, HLA DR1B, DW2.2/DR2.2, MHC class II antigen, lymphocyte antigen DRB1, MHC class II HLA-DRw10-beta, human leucocyte antigen DRB1, MHC class II HLA-DR beta 1Hu1D10, Apolizumab, 267227-08-7, 1D10, HU1D10, K8-355, HLA-DRB1, major histocompatibility complex, class II, DR beta 1, HLA DR1B, DW2.2/DR2.2, MHC class II antigen, lymphocyte antigen DRB1, MHC class II HLA-DRw10-beta, human leucocyte antigen DRB1, MHC class II HLA-DR beta 1, 阿泊珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG1；

宿主：；

CAS号：267227-08-7；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：；

产品背景：Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use.；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：ELISA, IP, FC, FuncS, Neut, IF, ICC；